LENSAR, Inc.

NasdaqCM LNSR

LENSAR, Inc. Net Income for the Trailing 12 Months (TTM) ending September 30, 2024: USD -16.63 M

LENSAR, Inc. Net Income is USD -16.63 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -20.19% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

LENSAR, Inc. Net Income for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -13.84 M, a 34.70% change year over year.
LENSAR, Inc. Net Income for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -21.19 M, a 5.95% change year over year.
LENSAR, Inc. Net Income for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -22.53 M, a -46.15% change year over year.
LENSAR, Inc. Net Income for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -15.41 M.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

NasdaqCM: LNSR

LENSAR, Inc.

CEO	Mr. Nicholas T. Curtis
IPO Date	Oct. 2, 2020
Location	United States
Headquarters	2800 Discovery Drive
Employees	130
Sector	Consumer Discretionary
Industries Eyewear 3D Printing Augmented Reality (AR) Biotechnology Glass Medical Instruments Robotics

Description

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Key trends

Past 5 years